Compare BDTX & OIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | OIO |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 139.7M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | OIO |
|---|---|---|
| Price | $2.67 | $3.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 619.0K | 53.6K |
| Earning Date | 05-11-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $2.72 |
| 52 Week High | $4.94 | $3.47 |
| Indicator | BDTX | OIO |
|---|---|---|
| Relative Strength Index (RSI) | 65.75 | 43.65 |
| Support Level | $2.45 | $2.83 |
| Resistance Level | $2.86 | $3.34 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 92.00 | 46.55 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.